These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12230247)

  • 1. Synthesis of 6-substituted 6H-indolo[2,3-b]quinolines as novel cytotoxic agents and topoisomerase II inhibitors.
    Kaczmarek L; Luniewski W; Zagrodzki B; Godlewska J; Osiadacz J; Wietrzyk J; Opolski A; Peczyńska-Czoch W
    Acta Pol Pharm; 2002; 59(3):199-207. PubMed ID: 12230247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.
    Godlewska J; Luniewski W; Zagrodzki B; Kaczmarek L; Bielawska-Pohl A; Dus D; Wietrzyk J; Opolski A; Siwko M; Jaromin A; Jakubiak A; Kozubek A; Peczyñska-Czoch W
    Anticancer Res; 2005; 25(4):2857-68. PubMed ID: 16080538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methoxy- and methyl-, methoxy-5,6,11-trimethyl-6H-indolo [2,3-b]quinolinium derivatives as novel cytotoxic agents and DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Opolski A; Wietrzyk J; Marcinkowska E; Boratyński J; Osiadacz J
    Anticancer Res; 1998; 18(4C):3133-8. PubMed ID: 9713522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
    Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
    J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
    Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
    Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
    Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
    Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
    Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
    Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.
    Lu CM; Chen YL; Chen HL; Chen CA; Lu PJ; Yang CN; Tzeng CC
    Bioorg Med Chem; 2010 Mar; 18(5):1948-57. PubMed ID: 20171108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial conversion of methyl- and methoxy- substituted derivatives of 5H-indolo[2,3-b]quinoline as a method of developing novel cytotoxic agents.
    Osiadacz J; Kaczmarek L; Opolski A; Wietrzyk J; Marcinkowska E; Biernacka K; Radzikowski C; Jon M; Peczyńska-Czoch W
    Anticancer Res; 1999; 19(4B):3333-42. PubMed ID: 10652630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzothiopyranoindole-based antiproliferative agents: synthesis, cytotoxicity, nucleic acids interaction, and topoisomerases inhibition properties.
    Dalla Via L; Magno SM; Gia O; Marini AM; Da Settimo F; Salerno S; La Motta C; Simorini F; Taliani S; Lavecchia A; Di Giovanni C; Brancato G; Barone V; Novellino E
    J Med Chem; 2009 Sep; 52(17):5429-41. PubMed ID: 19725581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives.
    Cheng Y; An LK; Wu N; Wang XD; Bu XZ; Huang ZS; Gu LQ
    Bioorg Med Chem; 2008 Apr; 16(8):4617-25. PubMed ID: 18296054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticancer evaluation of certain indolo[2,3-b]quinoline derivatives.
    Chen YL; Hung HM; Lu CM; Li KC; Tzeng CC
    Bioorg Med Chem; 2004 Dec; 12(24):6539-46. PubMed ID: 15556770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines.
    Ray S; Sadhukhan PK; Mandal NB; Mahato SB; Majumder HK
    Biochem Biophys Res Commun; 1997 Jan; 230(1):171-5. PubMed ID: 9020039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
    Han S; Xiao Z; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
    Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
    Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives.
    Ryckebusch A; Garcin D; Lansiaux A; Goossens JF; Baldeyrou B; Houssin R; Bailly C; Hénichart JP
    J Med Chem; 2008 Jun; 51(12):3617-29. PubMed ID: 18507368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel quinazoline-quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities.
    Ma Z; Hano Y; Nomura T; Chen Y
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1193-6. PubMed ID: 14980663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DNA topoisomerase II by azaelliptitoxins functionalized in the variable substituent domain.
    Tepe JJ; Madalengoitia JS; Slunt KM; Werbovetz KW; Spoors PG; Macdonald TL
    J Med Chem; 1996 May; 39(11):2188-96. PubMed ID: 8667362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.
    Bal C; Baldeyrou B; Moz F; Lansiaux A; Colson P; Kraus-Berthier L; Léonce S; Pierré A; Boussard MF; Rousseau A; Wierzbicki M; Bailly C
    Biochem Pharmacol; 2004 Nov; 68(10):1911-22. PubMed ID: 15476662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.